Who Will Be the 10 Largest Cardiovascular Companies in 2020?

Medtronic is poised to be the leading cardiovascular company over the next six years, according to a report from research firm EvaluateMedTech. With projected global sales of $11.1billion in 2020, the company would have a wide lead over the firm with the second biggest cardio business, St. Jude Medical. Rounding out the top five firms, both at present and in 2020, according to the research, are Boston Scientific, Abbott Laboratories, and Edwards Lifesciences.

Although the report didn't factor in Medtronic's planned acquisition of Covidien, the purchase would serve to bolster Medtronic's dominance in the cardiovascular sector. "With sales of $1.5bn forecast in 2020, Covidien sits just outside the top 10 cardiology companies at number 11," the report says. "Together the companies are forecast to achieve sales of $12.6bn in 2020, representing 22.0% market share."

The report authors note that General Electric and Philips do not disclose their cardiology sales figures.

Here is an image showing the top five firms along with their market share:

Image from EvaluateMedtech

Related articles

Find out the five biggest sectors in medtech and the firms that dominate them.

Huge mergers are going to change the worldwide medtech landscape in 2015. Find out how.